Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-06, Stock:ABBV, The news for the past five days is as follows:
2018-01-30: NEWS1: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.NEWS2: HCA Healthcare's (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS3: HCA Healthcare's (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS4: Top Stock Reports for Bank of America, Citigroup & AbbVie.NEWS5: HCA Healthcare&apos;s (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS6: Analysts Take Action on Healthcare Stocks.NEWS7: Pfizer sees upbeat 2018 on lower tax rate, shares dip after highs.NEWS8: 3 Big Biotech Stocks With Major Catalysts on the Way.NEWS9: 3 Big Biotech Stocks With Major Catalysts on the Way.NEWS10: Pfizer profit tops estimates, books $11 bln tax gain.NEWS11: 3 Big Biotech Stocks With Major Catalysts on the Way.
2018-01-31: NEWS1: Vertex Beats Views, Closes In On Cystic Fibrosis Treatments.NEWS2: Vertex Beats Views, Closes In On Cystic Fibrosis Treatments.NEWS3: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS4: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS5: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS6: Despite Tax-Cut, Pfizer Inc. Remains a Slow-Growth Company.NEWS7: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS8: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS9: AbbVie Is Ruining Pharma Earnings Season.NEWS10: The Zacks Analyst Blog Highlights: Bank of America, Citigroup, AbbVie, 3M, Starbucks and Halliburton.NEWS11: The Zacks Analyst Blog Highlights: Bank of America, Citigroup, AbbVie, 3M, Starbucks and Halliburton.NEWS12: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View.NEWS13: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View.NEWS14: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS15: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues &apos;18 View.NEWS16: The Zacks Analyst Blog Highlights: Bank of America, Citigroup, AbbVie, 3M, Starbucks and Halliburton.NEWS17: Johnson & Johnson’s Medical Devices Business in 4Q17.NEWS18: The Best Arthritis Drug/Treatment Stocks on the Market Right Now.NEWS19: The Best Arthritis Drug/Treatment Stocks on the Market Right Now.NEWS20: The Best Arthritis Drug/Treatment Stocks on the Market Right Now.NEWS21: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.NEWS22: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.
2018-02-01: NEWS1: Top 4 Marijuana Stocks to Watch.NEWS2: 5 Best Performing Stocks of January.NEWS3: 5 Best Performing Stocks of January.NEWS4: A Look at Analysts’ Estimates for Johnson & Johnson.NEWS5: Will Gilead (GILD) Disappoint Investors in Q4 Earnings?.NEWS6: Will Gilead (GILD) Disappoint Investors in Q4 Earnings?.NEWS7: Merck’s 4Q17 Estimates: Animal Health.NEWS8: Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi.NEWS9: Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi.NEWS10: Will Gilead (GILD) Disappoint Investors in Q4 Earnings?.NEWS11: Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi.NEWS12: Wired News – Shire Secured Exclusive Worldwide License to Develop and Commercialize AB Biosciences’ PRIM Program.NEWS13: Cramer Remix: Here are the best-in-show biotechs for 2018....NEWS14: Cramer Remix: AbbVie and Biogen are the best-in-show biotechs for 2018 so far.
2018-02-02: NEWS1: Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft.NEWS2: Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft.NEWS3: 5 Top Earnings Growth Stocks to Buy in February.NEWS4: 5 Top Earnings Growth Stocks to Buy in February.NEWS5: AstraZeneca (AZN) Beats on Q4 Earnings, Guides for 2018.NEWS6: Gilead's (GILD) HCV Segment to Decline Further in Q4 Earnings?.NEWS7: Gilead's (GILD) HCV Segment to Decline Further in Q4 Earnings?.NEWS8: 5 Top Earnings Growth Stocks to Buy in February.NEWS9: The Best Dividend Reinvestment Plans For 2018.NEWS10: Look Beyond Pharma to Invest in Marijuana Industry.NEWS11: 3 Top Biotherapeutics Stocks to Buy Now.NEWS12: 3 Top Biotherapeutics Stocks to Buy Now.NEWS13: 3 Top Biotherapeutics Stocks to Buy Now.
2018-02-05: NEWS1: Bristol-Myers (BMY) Beats on Q4 Earnings, Eliquis Impresses.NEWS2: Bristol-Myers (BMY) Beats on Q4 Earnings, Eliquis Impresses.NEWS3: Bristol-Myers (BMY) Beats on Q4 Earnings, Eliquis Impresses.NEWS4: The Zacks Analyst Blog Highlights: Sanofi, Seattle Genetics, AbbVie, Celgene and Vertex.NEWS5: The Zacks Analyst Blog Highlights: Sanofi, Seattle Genetics, AbbVie, Celgene and Vertex.NEWS6: 3 Top Pharmaceutical Stocks to Buy Now.NEWS7: 3 Top Pharmaceutical Stocks to Buy Now.NEWS8: The Zacks Analyst Blog Highlights: Sanofi, Seattle Genetics, AbbVie, Celgene and Vertex.NEWS9: 3 Top Pharmaceutical Stocks to Buy Now.NEWS10: How Is Big Business Using the Trump Tax Cut? What We Know So Far.

Answer: Rise